KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to -$27000.0.

  • Dynavax Technologies' Non Operating Income rose 8223.68% to -$27000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$701000.0, marking a year-over-year decrease of 6650.83%. This contributed to the annual value of $293000.0 for FY2024, which is 29276.32% up from last year.
  • Per Dynavax Technologies' latest filing, its Non Operating Income stood at -$27000.0 for Q3 2025, which was up 8223.68% from -$596000.0 recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Non Operating Income ranged from a high of $557000.0 in Q1 2021 and a low of -$596000.0 during Q2 2025
  • Its 5-year average for Non Operating Income is $7166.7, with a median of $31500.0 in 2022.
  • Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 33913.04% in 2024, then crashed by 51881.19% in 2025.
  • Over the past 5 years, Dynavax Technologies' Non Operating Income (Quarter) stood at $300000.0 in 2021, then crashed by 42.0% to $174000.0 in 2022, then crashed by 312.64% to -$370000.0 in 2023, then skyrocketed by 193.24% to $345000.0 in 2024, then plummeted by 107.83% to -$27000.0 in 2025.
  • Its Non Operating Income was -$27000.0 in Q3 2025, compared to -$596000.0 in Q2 2025 and -$423000.0 in Q1 2025.